From August 18th 2026, GtoPdb will require users to register to use the website. Please see our blog post for more information.

edotreotide   Click here for help

GtoPdb Ligand ID: 5638

Synonyms: DOTA-Tyr3-octreotide | DOTA0-Phe1-Tyr3-octreotide | Ga-DOTA-TOC | Ga-DOTATOC | SMT487 | SomaKit TOC®
Approved drug
edotreotide is an approved drug (EMA (2016))
Compound class: Peptide
Comment: Edotreotide is somatostatin receptor agonist. It is radiolabelled with gallium (68Ga) chloride for PET imaging.
Click here for help

Ligand Activity Visualisation Charts

These are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts.

✖

View interactive charts of activity data across species
No information available.
Summary of Clinical Use Click here for help
Edotreotide is used as a positron emission tomography (PET) imaging agent for gastroenteropancreatic neuroendocrine tumours.
External links Click here for help
For extended ADME data see the following:

European Medicines Agency (EMA)